# Psilocybin-assisted Group Therapy for Demoralization in Long-term AIDS Survivors

> **NCT02950467** · PHASE1 · COMPLETED · sponsor: **Joshua Woolley** · enrollment: 30 (actual)

## Conditions studied

- Distress
- Depression
- Grief

## Interventions

- **DRUG:** Psilocybin
- **BEHAVIORAL:** Modified brief Supportive Expressive Group Therapy

## Key facts

- **NCT ID:** NCT02950467
- **Lead sponsor:** Joshua Woolley
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-05
- **Primary completion:** 2019-12-31
- **Final completion:** 2019-12-31
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2021-01-07

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02950467

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02950467, "Psilocybin-assisted Group Therapy for Demoralization in Long-term AIDS Survivors". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02950467. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*